Director Nie Zenon S bought 11,915 shares of CRWS at $4.74 on 2024-09-09, raising stake to 80,294 shares (+17.4%)
Director Nie Zenon S purchased 11,915 shares at $4.74 on 2024-09-09, increasing his holdings by 17.4% to 80,294 shares total. This represents the insider's second consecutive buy at CRWS within three weeks (prior purchase on 2024-08-19), but his cross-ticker track record shows a mixed pattern: 2 prior buys averaging +1.5% over 30 days but -6.2% over 90 days, with a 0% win rate at the 90-day mark. At the same ticker, his prior buy on 2023-08-17 returned +1.5% in 30 days but -6.2% in 90 days, establishing a pattern of short-term resilience followed by longer-term weakness. The stock has since declined 4.7% over 30 days and 8.8% over 90 days from the transaction date; it currently trades at $4.69, down 20.5% from its 52-week high of $5.90. Fundamentals show the company posted $16.2M in quarterly revenue with a net loss of $322.0K and positive annual revenue growth of 16.8%, but the recent accumulation by the director lacks the timing pattern that would suggest conviction in a turning point.
Director Nie Zenon S bought 8,085 shares of CRWS at $4.60 on 2024-08-19; now holds 63,306 shares (+14.6%).
Director Nie Zenon S purchased 8,085 shares at $4.60, increasing his holdings by 14.6% from 55,221 to 63,306 shares. The purchase price of $4.60 was 0.4% below the current market price of $4.62, placing the trade near recent trading levels but at a discount to the 52-week high of $5.90. His prior buy at CRWS on 2023-08-17 did not result in positive 90-day returns, with a 90-day result of -6.2%; his cross-ticker track record shows 0 of 1 prior buys well-timed at the 90-day mark. The company's recent quarter shows modest fundamentals: $16.2M revenue with a net loss of $322.0K, though annual revenue growth is positive at +16.8%. The transaction reflects a modest absolute outlay of $37.2K in the context of a $47.6M market-cap company.
